[65] MUC1 Glycopeptide Vaccine Modified with a GalNAc Glycocluster Targets the Macrophage Galactose C-Type Lectin on Dendritic Cells to Elicit an Improved Humoral Response.

A. Gabba*, R. Attariya, S. Behren, C. Pett, J.C. van der Horst, H. Yurugi, J. Yu, M. Urschbach, J. Sabin, G. Birrane, E. Schmitt, S.J. van Vliet‡, P. Besenius‡, U. Westerlind‡, P.V. Murphy‡,J. Am. Chem. Soc. 2023, 24, 13027-13037. DOI: 10.1021/jacs.2c12843.  (Open Access)(‡ joint senior authors)